PSC
Patient Square Capital Portfolio holdings
AUM
$374M
1-Year Est. Return
90.79%
This Fund
S&P 500
1 Year Est. Return
+90.79%
AUM
$374M
AUM Growth
+$96.5M
(+35%)
Holding
27
Top Buys
| 1 | +$12.9M | |
| 2 | +$10.2M | |
| 3 | +$4.94M | |
| 4 |
Dianthus Therapeutics
DNTH
|
+$4.92M |
| 5 |
uniQure
QURE
|
+$4.38M |
Top Sells
| 1 | +$14.1M | |
| 2 | +$9.96M | |
| 3 | +$6.54M | |
| 4 |
Scholar Rock
SRRK
|
+$5.45M |
| 5 |
EyePoint Inc
EYPT
|
+$4.86M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cullinan Oncology
CGEM
$707M
| – | – |
-868,897
|
|
||
27
VYNE Therapeutics
VYNE
$18.8M
| – | – |
-317,033
|
|